Pharma distribution directory 2026
Pharmaceutical Distributors in Oman
Oman’s pharmaceutical trade is unusual in the Gulf because its largest distributors are also its largest pharmacy chains: family groups that hold import agencies for foreign brands, run wholesale depots and operate hundreds of retail counters under the same name.
The Ministry of Health registers medicines through its Directorate General of Pharmaceutical Affairs and Drug Control, and a locally licensed drug store must act as agent and importer. Public supply is centralised in the Directorate General of Medical Supplies in Muscat, which also participates in Gulf Health Council joint tenders, while private demand is met through the integrated pharmacy groups, private hospitals such as Badr Al Samaa and Aster Al Raffah, and two domestic manufacturers with local-preference status. The directory below lists the public buyer, the agent-chains, the manufacturers and the logistics groups, grouped so that a brand team can see which company plays which role along Oman’s long, thinly populated distribution routes.
$900m+
Omani pharmaceutical market, 2024 estimate
~1,000
Licensed private pharmacies
~70%
Share of medicine spend funded publicly (MOH, SQU, Royal Oman Police, PDO)
2
Domestic manufacturers supplying MOH tenders directly (OPP, NPI)
Top pharmaceutical distributors in Oman
Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against Oman Ministry of Health — Directorate General of Pharmaceutical Affairs and Drug Control, licensed drug stores and agents (as of 2026-09-03).
| Company | HQ |
|---|---|
| MOH Directorate General of Medical Supplies (DGMS) | Muscat |
| Gulf Health Council — Joint Procurement | Riyadh |
| Muscat Pharmacy & Stores | Muscat |
| Ibn Sina Pharmacy | Muscat |
| Mazoon Pharmacy | Muscat |
| Scientific Pharmacy | Muscat |
| Al Hashar Pharmacy | Muscat |
| Khimji Ramdas Healthcare | Muscat |
| Oman Pharmaceutical Products (OPP) | Salalah |
| National Pharmaceutical Industries (NPI) | Muscat |
| Aster Pharmacy Oman | Muscat |
| Asyad Group (Logistics) | Muscat |
| DHL Global Forwarding Oman | Muscat |
| Oman Air Cargo — Pharma | Muscat |
These are the distributors and wholesalers we map in Oman
Choosing or auditing a distribution partner in Oman? BioNixus runs distributor due-diligence interviews, channel-share estimates and pharmacy-level availability checks. Proposal ready within 48 hours of a brief.
Planning research in Oman?
Primary research, market access & HEOR. Proposals within 48 hours.
How pharmaceutical distribution works in Oman
An imported medicine enters Oman through the drug store named as agent on its MOH registration; that agent clears customs at Sohar, Muscat or Salalah and holds stock in its own warehouse. The public channel, which still funds most treatment, runs through the Directorate General of Medical Supplies, which issues annual tenders for MOH hospitals and health centres and receives deliveries at its central stores before onward distribution to governorates. Oman also buys selected products through the Gulf Health Council joint procurement programme, so some volumes are negotiated at GCC level and delivered through the agent. In the private channel the same agents sell to Badr Al Samaa, Aster Al Raffah, KIMS, Starcare and other private hospitals and to the roughly 1,000 pharmacies, a large share of which they own themselves under the Muscat Pharmacy, Ibn Sina, Mazoon, Scientific and Al Hashar banners. Oman Pharmaceutical Products and National Pharmaceutical Industries supply generics and IV fluids to MOH tenders directly and enjoy local-industry preference. Geography matters: covering Salalah, Sur, Nizwa and the interior requires regional depots, so distribution cost per pack is higher than in neighbouring Gulf states.
Local
Omani drug stores that hold import agencies, run wholesale depots and, in most cases, own pharmacy chains. Their integration means a brand’s agent choice also decides its retail shelf presence.
- ✓ Muscat Pharmacy & Stores
- ✓ Ibn Sina Pharmacy
- ✓ Mazoon Pharmacy
- ✓ Scientific Pharmacy
- ✓ Al Hashar Pharmacy
- ✓ Khimji Ramdas Healthcare
- ✓ Oman Pharmaceutical Products (OPP)
- ✓ National Pharmaceutical Industries (NPI)
Multinational
International freight and air-cargo providers that move temperature-sensitive product into Muscat, Sohar and Salalah for the agents and manufacturers.
- ✓ DHL Global Forwarding Oman
- ✓ Oman Air Cargo — Pharma
Regional
GCC-level procurement and Gulf trading groups that fold Oman into multi-country agreements, relevant for vaccines and for brands sequencing entry across the peninsula.
- ✓ Gulf Health Council — Joint Procurement
Wholesalers, importers & 3PL
The public buyer, the domestic manufacturers with tender preference, the provider-linked pharmacy chains and the state logistics platform that together define access to Omani patients.
- ✓ MOH Directorate General of Medical Supplies (DGMS)
- ✓ Aster Pharmacy Oman
- ✓ Asyad Group (Logistics)
What is moving pharma distribution in Oman
Dhamani mandatory health insurance
The phased Dhamani scheme obliges private employers to insure expatriate workers, moving prescriptions from out-of-pocket purchases into insured private hospitals and pharmacies and enlarging the channel served by agents outside MOH.
Local manufacturing and Vision 2040 localisation
OPP, NPI and new investments in Duqm and Salalah are expanding domestic production. Tender preference for national products pushes foreign brands toward local packaging or toll-manufacturing partnerships.
Consolidation of agent-chains
The integrated groups keep adding pharmacies and warehouse capacity, so listing negotiations with Muscat Pharmacy, Ibn Sina or Mazoon increasingly cover retail promotion as well as import terms.
Logistics build-out under Asyad
Investment in Sohar and Salalah ports, free-zone cold storage and road links to Saudi Arabia is lowering inbound costs and positioning Oman as a secondary entry point for GCC-bound pharma.
How BioNixus studies pharmaceutical distributors in Oman
The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in Oman:
- ✓Agent shortlisting for Omani entry: interviews with MOH and private hospital pharmacists, chain-pharmacy category managers and current principals to score coverage, tender record and retail integration.
- ✓DGMS tender landscaping: bidders, award prices, local-preference effects and delivery-performance feedback from central stores.
- ✓Retail availability audits across Muscat Pharmacy, Ibn Sina, Mazoon, Scientific and Al Hashar outlets in Muscat, Batinah and Dhofar.
- ✓Dhamani insurance channel tracking: how mandatory coverage is redistributing prescription volume between MOH facilities and private providers.
Frequently Asked Questions
Does a foreign pharmaceutical company need an Omani agent?
Yes. Registration with the Ministry of Health must be filed by a locally licensed drug store, which becomes the importer of record. The agent relationship is therefore inseparable from the product’s regulatory status in Oman.
Why do Omani distributors also own pharmacy chains?
Historically the same family groups obtained both import licences and pharmacy licences, and the small population made vertical integration the only way to reach scale. As a result, agency, wholesale and retail decisions in Oman are often made by the same management team.
How does Oman buy medicines for public hospitals?
Through the Directorate General of Medical Supplies, which runs annual MOH tenders and receives stock at central stores in Muscat, and through participation in Gulf Health Council joint procurement for selected products.
Which private hospitals are the key accounts for distributors in Oman?
Badr Al Samaa, Aster Al Raffah, KIMS Oman, Starcare and Burjeel Muscat operate most of the private beds and negotiate directly with agents, with their in-house pharmacies increasingly influencing brand choice for insured patients.
What does BioNixus research about pharmaceutical distribution in Oman?
Agent evaluation combining interviews with MOH pharmacists, private hospital purchasers and pharmacy managers; DGMS tender-outcome mapping; retail audits across the integrated chains to measure availability and shelf presence; and insured-channel tracking as Dhamani expands.
Are the companies here listed by market share?
They are not. The directory groups organisations by role and lists those that recur in BioNixus fieldwork across Oman, verified against MOH agent registrations; position does not indicate scale.
Data sources & methodology
This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in Oman. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.
Primary register: Oman Ministry of Health — Directorate General of Pharmaceutical Affairs and Drug Control, licensed drug stores and agents, consulted 2026-09-03. Company classification (Local / MNC / Regional / wholesalers, importers & 3pl) reflects ownership and role in Oman, not size.
- Directorate General of Medical Supplies tender notices and Oman Tender Board awards, 2024–2026
- National Centre for Statistics and Information health statistics, 2024
- Gulf Health Council joint procurement announcements, 2024–2025
- BioNixus Oman hospital pharmacy and pharmacy chain fieldwork, 2023–2026
BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.
Need distributor and channel data in Oman?
Coverage, credit terms, cold-chain capability and share of pharmacy purchases by wholesaler — from the pharmacies and hospitals themselves, not a directory.
Planning research in Oman?
Primary research, market access & HEOR. Proposals within 48 hours.